Islet-released mediators impact transplant outcome

September 7, 2017

(HealthDay)—Cytokines and chemokines produced by pancreatic islets in response to inflammatory and metabolic stress include interferon gamma-induced protein 10 (IP-10/CXCL10), which is associated with poor islet transplant outcomes, according to a study published in the September issue of Diabetes.

Gumpei Yoshimatsu, M.D., Ph.D., from the Baylor Research Institute in Dallas, and colleagues examined the physiological role of "isletokines" produced by in response to inflammatory and .

The researchers found that for patients undergoing , islets released multiple inflammatory mediators within hours of infusion. Among the highest-released was IP-10; high levels correlated with poor islet transplant outcomes. The contribution of donor islet-specific expression of IP-10 to islet inflammation and loss of beta-cell function in islet grafts was confirmed in transgenic mouse studies. Treatment of donor islets and recipient mice with anti-IP-10 neutralizing monoclonal antibody blocked the effects of islet-derived IP-10. IP-10 gene induction was mediated by calcineurin-dependent NFAT signaling in in response to oxidative or inflammatory stress. P38 and JNK MAP kinase (MAPK) activity were required for the sustained correlation of NFAT and p300 histone acetyltransferase with the IP-10 gene, which differentially regulated expression of IP-10 and subsequent release of protein.

"These findings elucidate an NFAT-MAPK signaling paradigm for induction of isletokine expression in beta-cells and reveal IP-10 as a primary therapeutic target to prevent beta-cell-induced inflammatory loss of graft function after islet cell transplantation," the authors write.

The study was funded in part by Roche Diagnostic Corp.

Explore further: The best place to treat type 1 diabetes might be just under your skin

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

The best place to treat type 1 diabetes might be just under your skin

August 14, 2017
A group of U of T researchers have demonstrated that the space under our skin might be an optimal location to treat type 1 diabetes (T1D).

New procedure could improve success rate of cell transplant to cure type 1 diabetes

April 4, 2016
New research suggests pretreating cells with a peptide hormone may improve the success rate of pancreatic islet cell transplants, a procedure that holds great promise for curing Type 1 diabetes. The results will be presented ...

Novel tissue-engineered islet transplant achieves insulin independence in type 1 diabetes

May 11, 2017
Scientists from the Diabetes Research Institute (DRI) at the University of Miami Miller School of Medicine have produced the first clinical results demonstrating that pancreatic islet cells transplanted within a tissue-engineered ...

Pancreatic islets infusion for diabetes patient being readied for procedure in Japan

May 16, 2012
The Japanese Pancreas and Islet Transplantation Association (JPITA) is preparing for the nation's first transplantation of pancreatic islets from a brain-dead donor to a patient with Type 1 diabetes, it was learned Saturday.

Recommended for you

Women with pregnancy-related diabetes may be at risk for chronic kidney disease

May 21, 2018
Gestational diabetes may predispose women to early-stage kidney damage, a precursor to chronic kidney disease, according to a study by researchers at the National Institutes of Health and other institutions. The study appears ...

Diabetes researchers find switch for fatty liver disease

May 17, 2018
Duke researchers have identified a key fork in the road for the way the liver deals with carbohydrates, fats and protein. They say it could be a promising new target for combating the pandemics of fatty liver disease and ...

New study of youth with type 1 diabetes connects 'honeymoon period' with lower LDL cholesterol

May 17, 2018
A new study by UMass Medical School physician-scientist Benjamin U. Nwosu, MD, finds that children with type 1 diabetes who experienced a partial clinical remission, or "honeymoon phase," had significantly lower low-density ...

"Living drug factories" may one day replace injections

May 17, 2018
Patients with diabetes generally rely on constant injections of insulin to control their disease. But MIT spinout Sigilon Therapeutics is developing an implantable, insulin-producing device that may one day make injections ...

Boosting the effects of vitamin D to tackle diabetes

May 10, 2018
More than 27 million people in the United States are living with type 2 diabetes, according to the Centers for Disease Control and Prevention. As the population ages and a growing percentage of people become overweight or ...

Very-low-carb diet shows promise in type 1 diabetes

May 7, 2018
Very-low-carbohydrate diets can improve blood sugar control in type 1 diabetes, with low rates of hypoglycemia and other complications, according to an online patient survey. The researchers, led by Belinda Lennerz, MD, PhD, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.